Filing metadata

Accession number
0001209191-21-020590
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Mar 15, 2021
Reporting period
Mar 12, 2021
Description
Insider transaction

Explore SEC Filings Hub